GHK-Cu (Max)
High-concentration copper tripeptide. Advanced remodelling research.
Specification
- Catalogue ID: VL-007-B
- Listed purity specification: 99.6%
- Formulation: Lyophilized
- Quantity: 100mg / Vial
- Price: £55.00
Extracellular matrix · copper signalling · gene expression
GHK-Cu (Max) is a higher-quantity presentation of the copper-binding tripeptide complex GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper), intended for laboratories requiring larger volumes or repeated in-vitro studies. The compound, formulation, and purity specification are identical to the standard 50 mg vial.
GHK-Cu has been studied in vitro for its role in extracellular-matrix biology, copper-ion chaperoning, and broad transcriptomic effects in human cell-culture models. Researchers studying collagen synthesis, metalloproteinase activity, or antioxidant-pathway gene expression commonly use this compound as a reference tool.
No physiological or therapeutic properties are claimed; supplied for in-vitro laboratory research use only.
Compound identity
- CAS number: 89030-95-5
- Molecular formula: C₁₄H₂₂CuN₆O₄
- Molecular weight: 341.83 Da
- Sequence: GHK
- Solubility: Soluble in water at ≥1 mg/mL
- Reconstitution: Add 1 mL sterile or bacteriostatic water per 5 mg; dissolve with gentle swirling
- Stability once reconstituted: Reconstituted solution stable for up to 14 days at 4 °C; avoid repeated freeze–thaw
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.